|
There must be a happy medium that can be reached between drug company profits and the public good. Insinuaiting that any cap at all would result in a loss of all r&d is not very logical. For all of the money drug companies spend on r&d they are still incredibly profitable.
That equilibrium must be possible but the companies will always claim that they will collapse if things change...that is what giant companies faced with regulation do. We have to come up with a better way to handle this than importing the drugs from a country that does have a sane drug policy.
|